InvestorsHub Logo
Followers 51
Posts 9209
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Friday, 10/06/2023 10:38:43 PM

Friday, October 06, 2023 10:38:43 PM

Post# of 13603
In 4Q23, we anticipate updated Ph2 efficacy data in adjuvant melanoma from the MRK-partnered individualized neotantigen therapy-------
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News